Neoclarityn is indicated for the relief of symptoms associated with: allergic rhinitis urticaria
CLARINEX — ORGANON, approved 2019-03-15 (NDA021165).
6,552 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.